Abstract
Background: The fruit of genus Rosa, known as "rose hip", is frequently used in different traditional medicines. Rose hips have long been used to treat kidney stones, gastroenteric ailments, hypertension and respiratory problems such as bronchitis, cough and cold.
Aim: This review is focused on the ethnopharmacological uses of rose hip as well as phytochemical and pharmacological aspects.
Results: Ethno-medical uses of rose hip have been recorded in many countries since a long time. Approximately, 129 chemical compounds have been isolated and identified from rose hip. This fruit contains some major active components such as flavonoids, tannins, anthocyanin, phenolic compounds, fatty oil, organic acids and inorganic compounds. Scientific studies have suggested a wide range of pharmacological activities for rose hip including antioxidant, anti-inflammatory, anti-obesity, anti-cancer, hepatoprotective, nephroprotective, cardioprotective, antiaging, anti H. pylori, neuroprotective and antinociceptive activities. In particular, the rose hip powder and extract have been reported to exert therapeutic effects on arthritis.
Conclusion: Some of the ethnomedical indications of rose hip, such as nephroprotective and gastroproetctive actions, have been confirmed by preclinical pharmacological studies. Additional investigations on the pharmacological effects of rose hip as well as evidence from randomized controlled trials are essential to assess the therapeutic value of this natural product.
Keywords: Rosa canina, cornuside, anti-cancer, protocatechuic acid, gallic acid, liver and kidney protection, osteoarthritis, linoleic acid, quercetin, palmitic acid, shikmic acid, apigenin, catechin, β- naringenin hexoside, rose hip, R. multiflora, Rosaceae.
Current Pharmaceutical Design
Title:Phytochemistry, Traditional Uses and Pharmacological Profile of Rose Hip: A Review
Volume: 24 Issue: 35
Author(s): Zahra Ayati, Mohammad S. Amiri, Mahin Ramezani, Elahe Delshad, Amirhossein Sahebkar and Seyed A. Emami*
Affiliation:
- Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad,Iran
Keywords: Rosa canina, cornuside, anti-cancer, protocatechuic acid, gallic acid, liver and kidney protection, osteoarthritis, linoleic acid, quercetin, palmitic acid, shikmic acid, apigenin, catechin, β- naringenin hexoside, rose hip, R. multiflora, Rosaceae.
Abstract: Background: The fruit of genus Rosa, known as "rose hip", is frequently used in different traditional medicines. Rose hips have long been used to treat kidney stones, gastroenteric ailments, hypertension and respiratory problems such as bronchitis, cough and cold.
Aim: This review is focused on the ethnopharmacological uses of rose hip as well as phytochemical and pharmacological aspects.
Results: Ethno-medical uses of rose hip have been recorded in many countries since a long time. Approximately, 129 chemical compounds have been isolated and identified from rose hip. This fruit contains some major active components such as flavonoids, tannins, anthocyanin, phenolic compounds, fatty oil, organic acids and inorganic compounds. Scientific studies have suggested a wide range of pharmacological activities for rose hip including antioxidant, anti-inflammatory, anti-obesity, anti-cancer, hepatoprotective, nephroprotective, cardioprotective, antiaging, anti H. pylori, neuroprotective and antinociceptive activities. In particular, the rose hip powder and extract have been reported to exert therapeutic effects on arthritis.
Conclusion: Some of the ethnomedical indications of rose hip, such as nephroprotective and gastroproetctive actions, have been confirmed by preclinical pharmacological studies. Additional investigations on the pharmacological effects of rose hip as well as evidence from randomized controlled trials are essential to assess the therapeutic value of this natural product.
Export Options
About this article
Cite this article as:
Ayati Zahra, Amiri S. Mohammad , Ramezani Mahin , Delshad Elahe, Sahebkar Amirhossein and Emami A. Seyed*, Phytochemistry, Traditional Uses and Pharmacological Profile of Rose Hip: A Review, Current Pharmaceutical Design 2018; 24 (35) . https://dx.doi.org/10.2174/1381612824666181010151849
DOI https://dx.doi.org/10.2174/1381612824666181010151849 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Pathophysiology of Uric Acid in Relation to Cardiovascular Disease
Current Cardiology Reviews Recent Updates on Transdermal Drug Delivery Approaches for the Management of Gout and its Clinical Perspective
Current Pharmaceutical Biotechnology Editorial [Hot Topic: Peripheral Proteins as Drug Targets (Guest Editor: Robert V. Stahelin) ]
Current Drug Targets MicroRNAs and Physical Activity
MicroRNA Nociceptin/Orphanin FQ Peptide Receptor as a Therapeutic Target for Obesity
Mini-Reviews in Medicinal Chemistry siRNA Targeting ECE-1 Partially Reverses Pulmonary Arterial Hypertensionassociated Damage in a Monocrotaline Model
Current Molecular Pharmacology Noncoding RNAs and Intracerebral Hemorrhage
CNS & Neurological Disorders - Drug Targets Diabetes and Its Complications: Therapies Available, Anticipated and Aspired
Current Diabetes Reviews Fat Digestion and its Role in Appetite Regulation and Energy Balance -The Importance of Enterostatin and Tetrahydrolipstatin
Current Medicinal Chemistry - Central Nervous System Agents Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry Medical Therapy for Long QT Syndrome
Mini-Reviews in Medicinal Chemistry MCI Patients in Europe: Medication and Comorbidities. The DESCRIPA Study
Current Alzheimer Research Patent Perspective for Potential Antioxidant Compounds-Rutin and Quercetin
Recent Patents on Nanomedicine Kidney CYP450 Enzymes: Biological Actions Beyond Drug Metabolism
Current Drug Metabolism Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Current Medicinal Chemistry Anti-Inflammatory Potential of Curcumin: From Chemistry and Mechanistic Insight to Nanoformulations
Current Bioactive Compounds Physiological and Molecular Role of Ranpirnase on Cancer Treatment
Current Cancer Therapy Reviews Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
Mini-Reviews in Medicinal Chemistry Cardiovascular Disease in the Systemic Vasculitides
Current Vascular Pharmacology Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets